Drug Shortage Report for AMPICILLIN SODIUM FOR INJECTION, USP

Last updated on 2021-11-25 History
Report ID 148421
Drug Identification Number 00872644
Brand name AMPICILLIN SODIUM FOR INJECTION, USP
Common or Proper name AMPICILLIN SODIUM INJ 250MG
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) AMPICILLIN
Strength(s) 250MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 10pk
ATC code J01CA
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2021-10-26
Estimated end date 2021-11-30
Actual end date 2021-11-24
Shortage status Resolved
Updated date 2021-11-25
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-11-25 French Compare
v3 2021-11-25 English Compare
v2 2021-10-28 French Compare
v1 2021-10-28 English Compare